Demonstrating dysregulation in the expression of tissue inhibitors of matrix metalloproteinases in the pathogenesis of keratoconus opens the way for further research on drugs modulating systemic and/or corneal and tear film related to TIMP levels, which could slow keratoconus progression and severity. Here, TIMP1 is linked to keratoconus.